BWI: GlaxoSmithKline Pharmaceuticals Net Sales up 14%, PBT before Exceptional Items grows by 14%

Press release from Business Wire India
Source: GlaxoSmithKline Pharmaceuticals Limited
Thursday, October 28, 2010 12:53 PM IST (07:23 AM GMT)
Editors: General: Consumer interest, Economy; Business: Banking & financial services, Business services, Financial Analyst, Healthcare, biotechnology & pharmaceutical, Stock exchanges; Healthcare
--------------------------------------------------
GlaxoSmithKline Pharmaceuticals Net Sales up 14%, PBT before Exceptional Items grows by 14%


Mumbai, Maharashtra, India, Thursday, October 28, 2010 -- (Business Wire India) -- GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2010. The Company has posted a Net Sales growth of 14% compared to the previous quarter, while Profit Before Tax and before Exceptional Items has grown by 14%, on a comparable basis. The core pharmaceutical business grew at 15%

Commenting on the performance, Dr. Hasit B. Joshipura, Managing Director, said, "The pharmaceutical business registered all round growth with the mass markets, mass specialities and specialities businesses all showing strong market competitive growth. The Company gained market share during the quarter. Vaccines registered a handsome growth as well. New products launched in the last two years continue to accelerate growth"

During the quarter, approval has been received for Revolade, a drug for low platelet counts and Votrient, for metastatic renal cell carcinoma.

About GlaxoSmithKline:

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk-india.com

To view the Unaudited Financial Results, please click on the link given below:

Unaudited Financial Results
For picture(s)/data to illustrate this release click below:

http://www.BusinessWireIndia.com/attachments/Unaudited_Financial_Results(6).pdf
Unaudited_Financial_Results(6).pdf


CONTACT DETAILS
Sunder Rajan, General Manager, Corporate Communications, GlaxoSmithKline Pharmaceuticals Limited, +91 (22) 24959203, sunder.r.rajan@gsk.com

KEYWORDS
CONSUMER, ECONOMY, BANKING, BUSINESS SERVICES, Financial Analyst, HEALTHCARE, STOCK EXCHANGES, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com